Ilyeon Pharmaceutical Decides on 80 Billion KRW Paid-in Capital Increase and Convertible Bond Issuance

[Asia Economy Reporter Minji Lee] Ilyeon Pharmaceutical announced that it has decided to issue the 2nd series of bearer, detachable warrant, unsecured private convertible bonds to raise facility funds. The total face value of the bonds is 70 billion KRW, with both the nominal interest rate and maturity interest rate set at 0%.

Additionally, it plans to raise 10 billion KRW in facility funds through a paid-in capital increase. The allottee is Quad Asset Management.